tailieunhanh - báo cáo hóa học:" The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ)"

Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí sinh học đề tài : The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ) | BioMed Central Health and Quality of Life Outcomes Research Open Access The reliability validity and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire EAPIQ Michael Alexander1 William Berger2 Patricia Buchholz3 John Walt4 Caroline Burk5 Jeff Lee4 Rob Arbuckle 6 and Linda Abetz6 Address 1Niagara Clinical Research 5673 North Street Niagara Falls Ont L2G1J4 Canada 2Southern California Research 27800 Medical Center Road Suite 240 Mission Viejo CA 92691 USA 3Allergan Inc. Ettlingen GmbH Pforzheimer Str. 160 Ettlingen 76275 Germany 4Allergan Inc. 2525 Dupont Drive Irvine CA 92612 USA 5CT Burk Inc. 1337 Cerritos Drive Laguna Beach CA 92651 USA and 6Mapi Values Ltd Adelphi Mill Grimshaw Lane Bollington Macclesfield Cheshire SK10 5JB UK Email Michael Alexander - doc911@ William Berger - weberger@ Patricia Buchholz - buchholz_patricia@ John Walt - Walt_john@ Caroline Burk - Burk_caroline@ Jeff Lee - Lee_jeff@ Rob Arbuckle - Linda Abetz - Corresponding author Published 31 October 2005 Received 18 August 2005 Health and Quality of Life Outcomes 2005 3 67 doi l477-7525-3-67 Accepted 31 October 2005 This article is available from http contenV3 1 67 2005 Alexander et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background The Eye Allergy Patient Impact Questionnaire EAPIQ was developed based on a pilot study conducted in the US and focus groups with eye allergy sufferers in Europe. The purpose of this study was to present the results of the psychometric validation of the EAPIQ. Methods One hundred forty six patients from two allergy clinics completed the EAPIQ .